2nd International Conference and Exhibition on Biowaivers & Biosimilars

Date: 23 – 25 September 2013

Location: Hilton, Raleigh-North Carolina, USA

OMICS Group invites all the participants across the globe to attend the 2^nd International Conference and Exhibition on Biowaivers and Biosimilars during September 23-25, 2013 Hilton, Raleigh, North Carolina, USA.

The patent expirations of generics have given a gateway to Biosimilars into the Global Pharmaceutical Economy since last few years. Though the regulatory prospects upon Follow-on Biologics were not much implemented in past years, the present circumstances of pharmaceutical R&Ds are worried about patent issues with generic drugs and their molecular entities.

The criteria required in filing of biological drugs will be discussed by popular agencies and their representatives in this meeting. Biosimilars trials and special case reports will be presented to denote the purpose and clinical data requirements for the future growth of Biosimilars and Biowaivers.

Biosimilars-2013 will provide an excellent and global opportunity to the scientists, partners and pharma leaders from Biopharmaceutical and Biotechnology industries to innovate and to explore the strategic market for Biosimilars and Biowaivers.

2nd International Conference and Exhibition on Biowaivers & Biosimilars

Date: 23 – 25 September 2013

Location: Hilton, Raleigh-North Carolina, USA

OMICS Group invites all the participants across the globe to attend the 2^nd International Conference and Exhibition on Biowaivers and Biosimilars during September 23-25, 2013 Hilton, Raleigh, North Carolina, USA.

The patent expirations of generics have given a gateway to Biosimilars into the Global Pharmaceutical Economy since last few years. Though the regulatory prospects upon Follow-on Biologics were not much implemented in past years, the present circumstances of pharmaceutical R&Ds are worried about patent issues with generic drugs and their molecular entities.

The criteria required in filing of biological drugs will be discussed by popular agencies and their representatives in this meeting. Biosimilars trials and special case reports will be presented to denote the purpose and clinical data requirements for the future growth of Biosimilars and Biowaivers.

Biosimilars-2013 will provide an excellent and global opportunity to the scientists, partners and pharma leaders from Biopharmaceutical and Biotechnology industries to innovate and to explore the strategic market for Biosimilars and Biowaivers.

Cell Culture Asia Congress 2013

Date:24 – 25 September

Location: Singapore

Oxford Global Conferences are proud to present the Cell Culture Asia Congress taking place on 24^th & 25^th September 2013 in Singapore. The congress is dedicated to the most pressing challenges and critical opportunities in the cell culture sector, creating a focused platform for scientific debate and executive-level networking.

Over the two days, the event will attract over 175 senior-level decision makers from Europe, the US and Asia with a comprehensive conference program featuring two separate streams, keynote addresses, case study presentations and interactive panel discussions given by expert speakers from global pharmaceutical organisations and leading research institutions.

Day One will examine the current trends and technologies in cell culture development and cell line optimisation. Our panel of experts will also discuss overcoming the most pressing challenges in cell line performance, contamination and authentication and cell culture media.

On Day Two hear how industry leaders are advancing raw material management and accelerating cell line development. Do not miss out on case studies examining disposable & single use technology, risk reduction strategies and achieving optimal biotherapeutic production.

The event will be co-located with Biosimilars Asia Congress, a high level meeting focused on biosimilars manufacturing, scale up, market opportunities and clinical trials.

2nd International Conference and Exhibition on Biowaivers & Biosimilars

Date: 23 – 25 September 2013

Location: Hilton, Raleigh-North Carolina, USA

OMICS Group invites all the participants across the globe to attend the 2^nd International Conference and Exhibition on Biowaivers and Biosimilars during September 23-25, 2013 Hilton, Raleigh, North Carolina, USA.

The patent expirations of generics have given a gateway to Biosimilars into the Global Pharmaceutical Economy since last few years. Though the regulatory prospects upon Follow-on Biologics were not much implemented in past years, the present circumstances of pharmaceutical R&Ds are worried about patent issues with generic drugs and their molecular entities.

The criteria required in filing of biological drugs will be discussed by popular agencies and their representatives in this meeting. Biosimilars trials and special case reports will be presented to denote the purpose and clinical data requirements for the future growth of Biosimilars and Biowaivers.

Biosimilars-2013 will provide an excellent and global opportunity to the scientists, partners and pharma leaders from Biopharmaceutical and Biotechnology industries to innovate and to explore the strategic market for Biosimilars and Biowaivers.

Cell Culture Asia Congress 2013

Date:24 – 25 September

Location: Singapore

Oxford Global Conferences are proud to present the Cell Culture Asia Congress taking place on 24^th & 25^th September 2013 in Singapore. The congress is dedicated to the most pressing challenges and critical opportunities in the cell culture sector, creating a focused platform for scientific debate and executive-level networking.

Over the two days, the event will attract over 175 senior-level decision makers from Europe, the US and Asia with a comprehensive conference program featuring two separate streams, keynote addresses, case study presentations and interactive panel discussions given by expert speakers from global pharmaceutical organisations and leading research institutions.

Day One will examine the current trends and technologies in cell culture development and cell line optimisation. Our panel of experts will also discuss overcoming the most pressing challenges in cell line performance, contamination and authentication and cell culture media.

On Day Two hear how industry leaders are advancing raw material management and accelerating cell line development. Do not miss out on case studies examining disposable & single use technology, risk reduction strategies and achieving optimal biotherapeutic production.

The event will be co-located with Biosimilars Asia Congress, a high level meeting focused on biosimilars manufacturing, scale up, market opportunities and clinical trials.